GB201001596D0 - S100 protein binding interaction inhibitors - Google Patents
S100 protein binding interaction inhibitorsInfo
- Publication number
- GB201001596D0 GB201001596D0 GBGB1001596.4A GB201001596A GB201001596D0 GB 201001596 D0 GB201001596 D0 GB 201001596D0 GB 201001596 A GB201001596 A GB 201001596A GB 201001596 D0 GB201001596 D0 GB 201001596D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- protein binding
- binding interaction
- interaction inhibitors
- inhibitors
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 102000013674 S-100 Human genes 0.000 title 1
- 108700021018 S100 Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 230000003993 interaction Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1001596.4A GB201001596D0 (en) | 2010-02-01 | 2010-02-01 | S100 protein binding interaction inhibitors |
| PCT/GB2011/050137 WO2011092505A1 (en) | 2010-02-01 | 2011-01-28 | S100 protein binding interaction inhibitors |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1001596.4A GB201001596D0 (en) | 2010-02-01 | 2010-02-01 | S100 protein binding interaction inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201001596D0 true GB201001596D0 (en) | 2010-03-17 |
Family
ID=42084271
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1001596.4A Ceased GB201001596D0 (en) | 2010-02-01 | 2010-02-01 | S100 protein binding interaction inhibitors |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB201001596D0 (en) |
| WO (1) | WO2011092505A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102603717A (en) * | 2012-01-09 | 2012-07-25 | 中国人民解放军第二军医大学 | Pyrrylketone compound and application thereof as drug |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080153791A1 (en) * | 2005-03-18 | 2008-06-26 | Onpharm Gmbh | 11Beta -Hydroxysteroid Dehydrogenases |
| US8138356B2 (en) * | 2007-10-16 | 2012-03-20 | Angiogeney, Inc. | Chemical inhibitors of inhibitors of differentiation |
| FR2929851B1 (en) * | 2008-04-09 | 2012-11-30 | Centre Nat Rech Scient | MOLECULES INHIBITING A METABOLIC PATHWAY INVOLVING THE TYROSINE KINASE SYK PROTEIN AND METHOD OF IDENTIFYING SAID MOLECULES |
| JP5637562B2 (en) * | 2008-09-25 | 2014-12-10 | 塩野義製薬株式会社 | Novel pyrrolinone derivative and pharmaceutical composition containing the same |
-
2010
- 2010-02-01 GB GBGB1001596.4A patent/GB201001596D0/en not_active Ceased
-
2011
- 2011-01-28 WO PCT/GB2011/050137 patent/WO2011092505A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011092505A1 (en) | 2011-08-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL271804A (en) | Mice that make binding proteins | |
| LTPA2019012I1 (en) | Plasma calcitrin binding proteins | |
| IL222323A0 (en) | Tnf - alpha binding proteins | |
| IL222980A0 (en) | Il-1 binding proteins | |
| ZA201300975B (en) | Binding proteins for hepcidin | |
| ZA201304905B (en) | TNF-a BINDING PROTEINS | |
| ZA201205624B (en) | Cd127 binding proteins | |
| ZA201206552B (en) | Therapeutic dll4 binding proteins | |
| SG10201401681PA (en) | Novel antigen binding proteins | |
| ZA201404481B (en) | Il-1 binding proteins | |
| GB201012603D0 (en) | Protein purification | |
| IL226157A0 (en) | Antigen binding proteins | |
| EP2569338A4 (en) | Binding systems | |
| SG10201503080XA (en) | Eif4e binding peptides | |
| GB201001596D0 (en) | S100 protein binding interaction inhibitors | |
| TWM400980U (en) | Binding | |
| GB201013489D0 (en) | Binding surfaces | |
| HK1186481A (en) | Amyloid-beta binding proteins | |
| HK1182395A (en) | Amyloid-beta binding proteins | |
| GB201003906D0 (en) | Binding polypeptides | |
| GB201010143D0 (en) | Comb binding |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |